Noveome Biotherapeutics' Private Equity Round

Noveome Biotherapeutics raised a round of funding on January 13, 2016. Investors include Ripplewood Holdings.

Noveome Biotherapeutics, formerly Stemnion, is regenerative medicine company focused on the research, development and clinical use of its technology platform, derived from human placental cells. This …

Articles about Noveome Biotherapeutics' Private Equity Round: